Unapproved transdermal delivery claim (no approved product)
GLP-1 Patches for Women: Do They Exist?
Medically reviewed by Editorial Medical Review, MD, NAMS-CMP · Updated July 2026
Quick answer
There is no FDA-approved transdermal GLP-1 patch. GLP-1 drugs such as semaglutide and tirzepatide are peptides given by injection, or as the Rybelsus tablet, and are not absorbed through the skin at therapeutic doses. For women, products marketed online as GLP-1 patches are unapproved and may be counterfeit.
How it works
GLP-1 receptor agonists are large peptide molecules that the skin does not absorb effectively, which is why approved products are injected or specially formulated as tablets. No transdermal GLP-1 patch has cleared FDA review.
FDA status for weight: No GLP-1 patch is FDA-approved for weight or any use. The FDA has warned about unapproved and counterfeit semaglutide products sold outside the regulated supply chain.
Women-specific considerations
These are factual notes from FDA labels and published guidelines, not personal medical advice. Discuss your situation with a licensed clinician.
Unknown contents
Because these products are unapproved, their contents, dose, and purity are unknown, so none of the pregnancy, breastfeeding, or contraception guidance for approved GLP-1 drugs can be reliably applied.
Counterfeit risk
The FDA has warned that unapproved and counterfeit weight-loss products can contain unexpected or unsafe ingredients, a particular concern for women seeking weight or PCOS support.
Use approved options instead
Approved GLP-1 options are injectable (Wegovy, Zepbound, Ozempic, Mounjaro) or the oral Rybelsus tablet, prescribed and monitored by a licensed clinician.
Who it is for (eligibility)
Not applicable, because no approved GLP-1 patch exists. Approved options are injectable (Wegovy, Zepbound, Ozempic, Mounjaro) or the oral tablet Rybelsus, prescribed by a licensed clinician.
Cost (cited)
No approved product
Pricing varies (unapproved)FDA — Medicines Containing Semaglutide, safety information ↗
Related questions
Frequently asked questions
- Is there a GLP-1 weight-loss patch?
- No. There is no FDA-approved transdermal GLP-1 patch. GLP-1 peptides are not absorbed through the skin at therapeutic doses, so approved products are injections or the Rybelsus tablet.
- Are online GLP-1 patches safe?
- Products sold online as GLP-1 patches are unapproved and may be counterfeit, with unknown contents. The FDA has warned about unapproved and counterfeit semaglutide products.
- What are the real GLP-1 options?
- The FDA-approved options are the injections Wegovy, Zepbound, Ozempic, and Mounjaro, and the oral tablet Rybelsus, each prescribed and monitored by a licensed clinician.
Sources
Every claim above resolves to an FDA label, published trial, guideline, or manufacturer / GoodRx pricing page. External links open in a new tab.
Compare other options
- Wegovy for women — GLP-1 receptor agonist (semaglutide 2.4 mg)
- Zepbound for women — GIP/GLP-1 receptor dual agonist (tirzepatide)
- Oral semaglutide (Rybelsus) for women — Oral GLP-1 receptor agonist (semaglutide tablet)
- Back to the GLP-1 for women guide
ClearHormones updates this explainer as FDA status and pricing change. Verify current approval status and pricing on the manufacturer or FDA page before acting.